Related Experiment Video
Updated: Sep 28, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
G-protein beta-3-subunit and eNOS gene polymorphism in transplant recipients with long-term renal graft function
Ondrej Viklický1, Jaroslav A Hubácek, Stefan Vítko
1Department of Nephrology, Institute for Clinical and Experimental Medicine, 1858/9 Videnská, CS-14021 Prague 4, Czech Republic. ondrej.viklicky@medicon.cz
Background:
Despite new immunosuppressive drugs, only a minority of graft survive over 15 years. The aim of our study was to determine the influence of gene polymorphisms in the G-protein-beta(3) subunit (Gbeta3) and endothelial nitric oxide synthase (eNOS) on the long-term outcome of kidney grafts.
Methods:
Using PCR, corresponding genotypes in Gbeta3 (C825T) and eNOS (G894T) gene polymorphism were evaluated in patients with preserved graft function over 15 years and in a control group of transplant recipients.
Results:
There were no differences in allele and genotype distributions of both polymorphisms between groups. In Gbeta3 polymorphism, the 825T allele carriers had a significantly lower body mass index while in eNOS polymorphism there were no links between genotypes, renal function and atherosclerosis risk factors.
Conclusions:
Our data suggest that these gene polymorphisms have only a minor influence on long-term renal graft function.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Kidney Transplant I: Introduction
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Kidney Transplant II: Surgical Procedure
